Skip to main content
Premium Trial:

Request an Annual Quote

LSBC Q4 Revenues Down Slightly; R&D Costs Up 87 Percent

NEW YORK, Feb 1 – Large Scale Biology's fourth quarter revenues decreased slightly from a year ago, the company reported Thursday. LSBC attributed the drop in revenue, from $5.9 to $5.7 million, primarily to decreased development funding from Dow Chemical and Dow AgroSciences.

Higher R&D costs in the fourth quarter of 2000 compounded the drop in contract funding from Dow, the company said. Compared to the year-ago fourth quarter, R&D expenditures were up 87 percent to $4.7 million.

LSBC reported a net loss of $2.3 million, or $0.09 per share, for the fourth quarter of 2000, compared to $1.1 million, or $0.12 per share for the last quarter of 1999.

The company predicted that quarterly earnings and R&D costs would fluctuate in 2001, as LSBC announces agreements with strategic partners.

" I am extremely pleased with the progress that the company has made during the year, said CEO Robert Erwin in a statement. “On the operational side, we achieved or exceeded all milestone requirements in our collaboration agreement with Dow and, we believe, laid the foundation for several collaborative deals, including the recently announced Biosite collaboration.”

On Tuesday, LSBC agreed to pay Biosite an undisclosed sum to develop antibodies for proteins contained in LSBC’s Human Protein Index and Molecular Anatomy and Pathology database. The two companies would then develop protein chips, and share in the profits from any diagnostic or protein chip product.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.